FDA Encourages Sponsors Of Hypertension Drugs To Promote Their Cardiovascular Benefits
This article was originally published in The Pink Sheet Daily
Executive Summary
Final guidance allowing class-wide outcomes claims includes suggested language for both advertising and labeling.